Dimitris Karagiannis

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 10, 2023
Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumors.

Dimitris Karagiannis, Warren Wu, Albert Li

|Apr 23, 2022
Cancer Evolution in Precision Medicine Era.

Dimitris Karagiannis, Theodoros Rampias

|Jul 24, 2021
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity.

Dimitris Karagiannis, Theodoros Rampias

|Jan 23, 2019
The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer.

Theodoros Rampias, Dimitris Karagiannis, Margaritis Avgeris

Pageof 1